Gilmelisib free base

Gilmelisib is an antineoplastic.

For research use only. Not for human or veterinary use.

Target PI3K

Research area Cancer

Purity >98% Stock Inquire

Data Sheet SDS COA

Gilmelisib structure

CAS No.: 1845777-61-8

Pack sizes & pricing

Size	Price	SKU	Stock
10 mg	USD 550.00	BP-02232-10mg	In stock	Get quote
25 mg	USD 885.00	BP-02232-25mg	In stock	Get quote
50 mg	USD 1,285.00	BP-02232-50mg	In stock	Get quote
100 mg	USD 1,885.00	BP-02232-100mg	In stock	Get quote
250 mg	USD 2,885.00	BP-02232-250mg	In stock	Get quote
500 mg	USD 3,980.00	BP-02232-500mg	In stock	Get quote

Need another size or custom synthesis? Request a quote.

Gilmelisib is an antineoplastic. Gilmelisib is a PI3K inhibitor (IC50 <1 nM for PI3K p110α) extracted from WO2017101847 A1, compound 1.

Gilmelisib is an antineoplastic. Gilmelisib is a PI3K inhibitor (IC50 <1 nM for PI3K p110α).

MW (average): 547.9860
Formula: C₂₄H₂₃ClFN₅O₅S
CAS No.: 1845777-61-8
Physical state: Solid
Color: White to yellow
Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage: Powder -20℃ 3 years; In solvent -20℃ 1 month;

DMSO 5 mg/mL (ultrasonic and warming and adjust pH to 4 with HCl and heat to 60°C)

[1]. WO2017101847 A1

[2]. International Nonproprietary Names for Pharmaceutical Substances (INN)

Search PI3K

Search Cancer